Heron Therapeutics
HRTX
#7580
Rank
S$0.36 B
Marketcap
$2.41
Share price
0.00%
Change (1 day)
-34.66%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.60

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.53. In 2022 the company made an earnings per share (EPS) of -$2.27 an increase over its 2021 EPS that were of -$2.95.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.60-29.22%
2022-$2.27-23.11%
2021-$2.95-10%
2020-$3.28-0%
2019-$3.281.21%
2018-$3.24-32.7%
2017-$4.81-19.34%
2016-$5.9654.76%
2015-$3.851.73%
2014-$3.79-16.23%
2013-$4.5291.67%
2012-$2.36-31.45%
2011-$3.44-27.06%
2010-$4.72-43.75%
2009-$8.39-57.33%
2008-$19.66-82.92%
2007-$115.0820.61%
2006-$95.42175.76%
2005-$34.60-21.43%
2004-$44.04100%
2003-$22.02-38.24%
2002-$35.65161.54%
2001-$13.63-106.46%
2000$210.892051.55%
1999$9.80839.73%
1998$1.04-105.48%
1997-$19.05-88.16%
1996-$160.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.70-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.18-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.14 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.06-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.16 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA